Evidence map›Paper›PMID 35358724›Full record

ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Antimicrobial Resistance Through the Lens of One Health in Ethiopia: A Review of the Literature Among Humans, Animals, and the Environment.

Ayako Wendy Fujita, Kaitlyn Werner, Jesse T Jacob, Rea Tschopp, Gezahegne Mamo, Adane Mihret, Alemseged Abdissa, Russell Kempker, Paulina A Rebolledo

Open access · goldAbstract readReview
In one paragraph

Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
3.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Antimicrobial resistance profile ofFrontiers in public health · 2024
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Resistome and Phylogenomics ofAntibiotics (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Ayako Wendy FujitaEmory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia, United States. Electronic address: afujita@emory.edu.
Kaitlyn WernerEmory University, Rollins School of Public Health, Atlanta, GA, United States.
Jesse T JacobEmory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia, United States.
Rea TschoppArmauer Hansen Research Institute, Addis Ababa, Ethiopia; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Gezahegne MamoAddis Ababa University, College of Veterinary Medicine and Agriculture, Department of Microbiology, Immunology and Veterinary Public Health, Addis Ababa, Ethiopia.
Adane MihretArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Alemseged AbdissaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Russell KempkerEmory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia, United States.
Paulina A RebolledoEmory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia, United States.
Emory University · USArmauer Hansen Research Institute · ETAddis Ababa University · ETSwiss Tropical and Public Health Institute · CH

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
J: NRSA Training CoreTL1TR002382 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Vasiliki Michopoulos · 2017 to 2026
$8.5M
NCATS NIH HHS TL1 TR002382NCATS NIH HHS UL1 TR002378
6 · The paper itself

Abstract

objectivesWe aimed to review and describe antimicrobial resistance (AMR) prevalence in humans, animals, and the environment in Ethiopia.

methodsWe conducted a structured review of literature on AMR in humans, animals, and the environment in Ethiopia from 2016-2020. We reported the pooled prevalence of AMR of bacterial pathogens in all 3 sectors.

resultsWe included 43 articles in our review. Only 5 studies evaluated AMR across multiple sectors. The most common bacteria in humans were Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. High prevalence of resistance to third-generation cephalosporins, fluoroquinolones, and sulfamethoxazole-trimethoprim were seen in gram-negative organisms, often with >50% prevalence of resistance. Highest resistance rates were seen in humans, followed by environmental isolates. Salmonella spp. exhibited higher rates of resistance than previously reported in the literature. We found methicillin-resistant S. aureus (MRSA) in approximately half of S. aureus from the environment and a third from human isolates. Few studies evaluated AMR across all 3 sectors.

conclusionOur review demonstrated high prevalence of AMR among bacteria in humans, animals, and the environment in Ethiopia. Integrating a One Health approach into AMR surveillance as part of Ethiopia's national surveillance program will inform future implementation of One Health interventions.

Indexed as

Methicillin-Resistant Staphylococcus aureusOne HealthAnimalsAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialEscherichia coliEthiopiaHumansMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial Agentsantimicrobial resistanceEthiopiaOne Health

Identifiers

PMID35358724
PMCPMC9107604
OpenAlexW4220699556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.